Inicia sesión Registrate Mi Biblioteca biblioteca abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por la International Parkinson & Movement Disorder Society.

Tratamiento no farmacológico

364 ARTíCULOS , VIENDO DEL 256 AL 270

PUBMED

Alzheimer disease therapy--moving from amyloid-β to tau

Giacobini E, Gold G.

Nat Rev Neurol. 2013 Dec;9(12):677-86. doi: 10.1038/nrneurol.2013.223. Epub 2013 Nov 12.

0

0

0

PUBMED

[Cholesterol inhibitor and memantine in symptomatic dementia therapy]

Rodda J, Carter J.

Praxis (Bern 1994). 2013 Feb 27;102(5):293-300; discussion 298-9. doi: 10.1024/1661-8157/a001209.

0

0

0

PUBMED

Inhibitors of BACE for treating Alzheimer's disease: a fragment-based drug discovery story

Stamford A, Strickland C.

Curr Opin Chem Biol. 2013 Jun;17(3):320-8. doi: 10.1016/j.cbpa.2013.04.016. Epub 2013 May 14.

0

0

0

PUBMED

A brief review on studies of Alzheimer's disease in China: its mechanism, imaging and therapy

Shi H, Wang Z.

Sci China Life Sci. 2013 Dec;56(12):1142-4. doi: 10.1007/s11427-013-4566-1. Epub 2013 Dec 5.

0

0

0

PUBMED

Dual inhibitors of monoamine oxidase and cholinesterase for the treatment of Alzheimer disease

Yáñez M, Viña D.

Curr Top Med Chem. 2013;13(14):1692-706. doi: 10.2174/15680266113139990120.

0

0

0

PUBMED

Multifunctional tacrine derivatives in Alzheimer's disease

Minarini A, Milelli A, Simoni E, Rosini M, Bolognesi ML, Marchetti C, Tumiatti V.

Curr Top Med Chem. 2013;13(15):1771-86. doi: 10.2174/15680266113139990136.

0

0

0

PUBMED

Progress of "Current Alzheimer Research" and future direction

Lahiri DK.

Curr Alzheimer Res. 2013 Jan;10(1):1-3. doi: 10.2174/1567205011310010001.

0

0

0

PUBMED

Who is that stranger in the mirror? The mirror experience for elderly patients with dementia

Kelsick JR, Freysteinson WM.

Holist Nurs Pract. 2013 Sep-Oct;27(5):268-72. doi: 10.1097/HNP.0b013e31829b924a.

0

0

0

PUBMED

[Alzheimer's disease and depression]

Mizukami K.

Seishin Shinkeigaku Zasshi. 2013;115(11):1122-6.

0

0

0

PUBMED

Diagnosis and management of Alzheimer's disease: past, present and future ethical issues

Gauthier S, Leuzy A, Racine E, Rosa-Neto P.

Prog Neurobiol. 2013 Nov;110:102-13. doi: 10.1016/j.pneurobio.2013.01.003. Epub 2013 Apr 8.

0

0

0

PUBMED

Alzheimer's disease drug discovery: in vivo screening using Caenorhabditis elegans as a model for β-amyloid peptide-induced toxicity

Lublin AL, Link CD.

Drug Discov Today Technol. 2013 Spring;10(1):e115-e119. doi: 10.1016/j.ddtec.2012.02.002.

0

0

0

PUBMED

Natural products for Alzheimer's disease therapy: basic and application

Xiao J, Tundis R.

J Pharm Pharmacol. 2013 Dec;65(12):1679-80. doi: 10.1111/jphp.12186.

0

0

0

PUBMED

Animal systems in the development of treatments for Alzheimer's disease: challenges, methods, and implications

Sabbagh JJ, Kinney JW, Cummings JL.

Neurobiol Aging. 2013 Jan;34(1):169-83. doi: 10.1016/j.neurobiolaging.2012.02.027. Epub 2012 Apr 1.

0

0

0

PUBMED

The role of nutrition and diet in Alzheimer disease: a systematic review

Shah R.

J Am Med Dir Assoc. 2013 Jun;14(6):398-402. doi: 10.1016/j.jamda.2013.01.014. Epub 2013 Feb 16.

0

0

0

PUBMED

[Bed-manager or health-care circuit manager]

Cieslik M, Legendre M, de Decker L, Berrut G.

Geriatr Psychol Neuropsychiatr Vieil. 2013 Dec;11(4):337-8. doi: 10.1684/pnv.2013.0429.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neuroacademy